Bill > S06352

This bill amends New York's education law to include nurse practitioners as providers who can participate in collaborative drug therapy management (CDTM), a process where pharmacists work directly with healthcare providers to review, evaluate, and manage patient drug therapy. The bill makes several key changes: it expands the definition of who can engage in CDTM to include nurse practitioners alongside physicians, allows pharmacists to adjust drug regimens within specific protocols (such as changing drug strength or frequency), and permits up to fifteen community-practice sites to implement these collaborative arrangements. To participate, pharmacists must meet specific educational and experience requirements, such as having a master's or doctorate in clinical pharmacy, maintaining an unrestricted license, and having at least two years of clinical experience. The bill also emphasizes that participation is voluntary, requires patient written consent, and maintains that the physician or nurse practitioner's judgment takes precedence in case of disagreement. Additionally, the bill makes permanent the previous temporary authorization for pharmacists to perform collaborative drug therapy management, removing the previous sunset provision that would have expired the program in July 2026. The overall goal is to enhance patient care by allowing pharmacists and healthcare providers to work more collaboratively in managing medication treatments.

Education

https://www.nysenate.gov/legislation/bills/2025/S6352